http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114634980-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e07d4825923c9a2f2f4ab833eaded200 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate | 2020-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f513b14dc07247f790b99dba62b7257e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c12a304b9f9f2cfc69a1760fe64ba49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ee69f87c9feab7f84279d3f1b38c467 |
| publicationDate | 2022-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114634980-A |
| titleOfInvention | A serum miRNA marker combination for auxiliary diagnosis of lung cancer and its detection kit |
| abstract | Lung cancer is a common malignant tumor. The latest statistics show that among malignant tumors in the world, the incidence rate is the first, and the mortality rate is the first. Early diagnosis of lung cancer can significantly improve patient survival. The invention relates to a peripheral blood miRNA marker combination for auxiliary diagnosis of lung cancer and a detection kit thereof, comprising hsa-miR-545-5p, hsa-miR-514b-5p, hsa-miR-590- 5p, hsa-miR-627-5p and hsa-miR-653-5p, the internal reference gene is U6, and specific primers for the above miRNAs are provided. It also provides the necessary reagents for the detection of positive quality control products, negative quality control products, poly-A tailing enzyme, reverse transcriptase and other kits, and the technical solutions required to achieve the detection purpose. The invention can detect the abnormal increase of some tumor-derived miRNAs in serum at an earlier stage, and can be used for auxiliary diagnosis of early clinical lung cancer. |
| priorityDate | 2020-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.